Showing results (1-10 of 10,058) with videos related to
Sort By:
Pageof 1,006
Current Pharmaceutical Design|July 23, 2003
Inhibitors of the proteolytic activity of urokinase type plasminogen activatorTodd W Rockway, Vincent L GirandaCurrent Pharmaceutical Design|July 23, 2003
Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodelingSteingrimur Stefansson, Grainne A McMahon, Eric Petitclerc, et al.Current Pharmaceutical Design|July 23, 2003
Urokinase receptor and integrin interactionsMatthias C Kugler, Ying Wei, Harold A ChapmanCurrent Pharmaceutical Design|July 23, 2003
Immune abnormalities and endotoxemia in patients with ulcerative colitis and in their first degree relatives: attempts at neutralizing endotoxin-mediated effectsL Amati, L Caradonna, G Leandro, et al.Current Pharmaceutical Design|July 23, 2003
Probiotic lactobacilli: a new perspective for the treatment of inflammatory bowel diseaseGiuseppe Famularo, Luciana Mosca, Giovanni Minisola, et al.Current Pharmaceutical Design|July 23, 2003
Gene therapy of cancer with interleukin-12Guillermo Mazzolini, Jesús Prieto, Ignacio MeleroCurrent Pharmaceutical Design|July 23, 2003
BLyS: the pivotal determinant of peripheral B cell selection and lifespanSusan Harless Smith, Michael P CancroCurrent Pharmaceutical Design|July 23, 2003
Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implicationsAlejandro Ruiz-Argüelles, Liliana Rivadeneyra-Espinoza, Donato Alarcón-SegoviaCurrent Pharmaceutical Design|July 23, 2003
Comparative QSAR based on neural networks for the anti-HIV activity of HEPT derivativesL Douali, D Villemin, D CherqaouiPageof 1,006